CONFIRM: Magnetic Resonance Guided Radiation Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2029-06-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to determine the safety and feasibility of using a type of radiation guided by magnetic resonance imaging (MRI) and chemotherapy to treat patients with gastric and breast cancer. The name of the radiation machine involved in this study is the MRIdian Linear Accelerator.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)

NCT04135794

Cancer

RECRUITING

MR-Linac for Head and Neck SBRT

NCT04809792

Head and Neck Cancer

NOT_YET_RECRUITING NA

Receiving Radiation Therapy in the MRgRT Research Facility

NCT02701712

Solid Tumors and Metastatic Lesions

RECRUITING NA

Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

NCT04172753

Rectal Cancer Head and Neck Cancer Liver Cancer +4 more

RECRUITING NA

Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine

NCT03878485

Oligometastases of the Spine

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a master clinical protocol evaluating magnetic resonance (MR) image guided radiation in patients with gastric and breast cancer.

In this research study, the investigators are researching if getting an MRI during radiation is a feasible way to delivery radiation. In this research study, a MRI done during treatment will help doctors adapt the radiation to target the most precise spot where the cancer is located.

The research study procedures include:

* Screening for eligibility
* Study treatment including evaluations
* Follow up visits
* Questionnaires

This is a Phase I/II clinical trial. A Phase I clinical trial tests the safety of investigational radiation treatment and also tries to define the appropriate dose of the investigational radiation treatment to use for further studies. "Investigational" means that the way the radiation treatment is delivered is being studied.

This research study is a Feasibility Study, which means it is the first-time investigators at this institution are examining this type of MR-guided radiation. Investigators at other hospitals and academic centers are already using this type of radiation.

The U.S. Food and Drug Administration (FDA) has approved this radiation machine and these drugs as treatment options for gastric and breast cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer Invasive Breast Cancer in Situ Breast Cancer Mantle Cell Lymphoma Larynx Cancer Bladder Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Intervention Type RADIATION

MR-image guided radiation will be administered per disease site standards.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Viewray MRIdian® Linac

MR-image guided radiation will be administered per disease site standards.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must have histologically or cytologically confirmed malignancy requiring radiation
* Age 18 years of older
* ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)
* Ability to understand and the willingness to sign a written informed consent document.
* Any further criteria listed in the specific disease site cohort

Exclusion Criteria

* History of allergic reactions attributed to gadolinium-based IV contrast

\-- Note: If patient will not receive contrast, this is not applicable and kidney function will not affect eligibility
* Severe claustrophobia or anxiety
* Participants who cannot undergo an MRI

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No